Azizi F, Hadaegh F, Hosseinpanah F, Mirmiran P, Amouzegar A, Abdi H, Asghari G, Parizadeh D, Montazeri SA, Lotfalian M, et al. Metabolic health in the Middle East and north Africa. Lancet Diabetes Endocrinol. 2019;7:866–79.
Article
PubMed
Google Scholar
Esteghamati A, Larijani B, Aghajani MH, Ghaemi F, Kermanchi J, Shahrami A, Saadat M, Esfahani EN, Ganji M, Noshad S. Diabetes in Iran: prospective analysis from first nationwide diabetes report of National Program for Prevention and Control of Diabetes (NPPCD-2016). Sci Rep. 2017;7(1):1–10.
Article
CAS
Google Scholar
Moazzeni SS, Ghafelehbashi H, Hasheminia M, Parizadeh D, Ghanbarian A, Azizi F, Hadaegh F. Sex-specific Prevalence of coronary heart disease among Tehranian adult population across different glycemic status: Tehran lipid and glucose study, 2008–2011. BMC Public Health. 2020;20:1–9.
Article
CAS
Google Scholar
Derakhshan A, Sardarinia M, Khalili D, Momenan AA, Azizi F, Hadaegh F. Sex specific incidence rates of type 2 diabetes and its risk factors over 9 years of follow-up: Tehran lipid and glucose study. PLoS ONE. 2014;9(7):e102563.
Article
PubMed
PubMed Central
CAS
Google Scholar
Ramezankhani A, Harati H, Bozorgmanesh M, Tohidi M, Khalili D, Azizi F, Hadaegh F. Diabetes mellitus: findings from 20 years of the Tehran lipid and glucose study. Int J Endocrinol Metab. 2018;16(4 Suppl):e84784.
PubMed
PubMed Central
Google Scholar
Brown R, Kuk J. Consequences of obesity and weight loss: a devil’s advocate position. Obes Rev. 2015;16(1):77–87.
Article
CAS
PubMed
Google Scholar
Group LAR. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369(2):145.
Article
CAS
Google Scholar
Care F. Standards of medical care in diabetes 2019. Diabetes Care. 2019;42(Suppl 1):S124–38.
Google Scholar
Gaddey HL, Holder K. Unintentional weight loss in older adults. Am Fam Physician. 2014;89(9):718–22.
PubMed
Google Scholar
Nam GE, Kim W, Han K, Lee C-W, Kwon Y, Han B, Park S, Park J-H, Kim Y-H, Kim D-H. Body weight variability and the risk of cardiovascular outcomes and mortality in patients with type 2 diabetes: a nationwide cohort study. Diabetes Care. 2020;43(9):2234–41.
Article
PubMed
Google Scholar
Lee H-J, Choi E-K, Han K-D, Kim DH, Lee E, Lee S-R, Oh S, Lip GY. High variability in bodyweight is associated with an increased risk of atrial fibrillation in patients with type 2 diabetes mellitus: a nationwide cohort study. Cardiovasc Diabetol. 2020;19(1):1–10.
Article
CAS
Google Scholar
Hurren KM, Dunham MW. Understanding the impact of commonly utilized, non-insulin, glucose-lowering drugs on body weight in patients with type 2 diabetes. Expert Opin Pharmacother. 2018;19(10):1087–95.
Article
CAS
PubMed
Google Scholar
Chen Y, Yang X, Wang J, Li Y, Ying D, Yuan H. Weight loss increases all-cause mortality in overweight or obese patients with diabetes: a meta-analysis. Medicine. 2018;97(35):e12075.
Article
PubMed
PubMed Central
Google Scholar
Strelitz J, Ahern AL, Long GH, Hare MJ, Irving G, Boothby CE, Wareham NJ, Griffin SJ. Moderate weight change following diabetes diagnosis and 10 year incidence of cardiovascular disease and mortality. Diabetologia. 2019;62(8):1391–402.
Article
PubMed
PubMed Central
Google Scholar
Doehner W, Gerstein HC, Ried J, Jung H, Asbrand C, Hess S, Anker SD. Obesity and weight loss are inversely related to mortality and cardiovascular outcome in prediabetes and type 2 diabetes: data from the ORIGIN trial. Eur Heart J. 2020;41(28):2668–77.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lee AK, Woodward M, Wang D, Ohkuma T, Warren B, Sharrett AR, Williams B, Marre M, Hamet P, Harrap S. The risks of cardiovascular disease and mortality following weight change in adults with diabetes: results from ADVANCE. J Clin Endocrinol Metab. 2020;105(1):152–62.
Article
Google Scholar
Kim MK, Han K, Koh ES, Kim ES, Lee M-K, Nam GE, Kwon H-S. Weight change and mortality and cardiovascular outcomes in patients with new-onset diabetes mellitus: a nationwide cohort study. Cardiovasc Diabetol. 2019;18(1):36.
Article
PubMed
PubMed Central
Google Scholar
Strelitz J, Sharp SJ, Khunti K, Vos RC, Rutten GE, Webb DR, Witte DR, Sandbæk A, Wareham NJ, Griffin SJ. Association of weight loss and weight loss maintenance following diabetes diagnosis by screening and incidence of cardiovascular disease and all-cause mortality: an observational analysis of the ADDITION-Europe trial. Diabetes Obes Metab. 2020;23(3):730–41.
Article
PubMed
Google Scholar
Xing Z, Pei J, Huang J, Peng X, Chen P, Hu X, Gao S. Weight change is associated with increased all-cause mortality and non-cardiac mortality among patients with type 2 diabetes mellitus. Endocrine. 2019;64(1):82–9.
Article
CAS
PubMed
Google Scholar
Bodegard J, Sundström J, Svennblad B, Östgren CJ, Nilsson P, Johansson G. Changes in body mass index following newly diagnosed type 2 diabetes and risk of cardiovascular mortality: a cohort study of 8486 primary-care patients. Diabetes Metab. 2013;39(4):306–13.
Article
CAS
PubMed
Google Scholar
Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, Mehrabi Y, Zahedi-Asl S. Prevention of non-communicable disease in a population in nutrition transition: Tehran lipid and glucose study phase II. Trials. 2009;10(1):5.
Article
PubMed
PubMed Central
Google Scholar
Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, Van Lente F, Collaboration CKDE. Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007;53(4):766–72.
Article
CAS
PubMed
Google Scholar
Stevens J, Truesdale KP, McClain JE, Cai J. The definition of weight maintenance. Int J Obes. 2006;30(3):391–9.
Article
CAS
Google Scholar
Van Buuren S. Flexible imputation of missing data. Boca Raton: CRC Press; 2018.
Book
Google Scholar
Steyerberg EW. Clinical prediction models. Cham: Springer; 2019.
Book
Google Scholar
Aucott LS, Philip S, Avenell A, Afolabi E, Sattar N, Wild S. Patterns of weight change after the diagnosis of type 2 diabetes in Scotland and their relationship with glycaemic control, mortality and cardiovascular outcomes: a retrospective cohort study. BMJ Open. 2016;6(7):e010836.
Article
PubMed
PubMed Central
Google Scholar
Jenkins DA, Wade KH, Carslake D, Bowden J, Sattar N, Loos RJ, Timpson NJ, Sperrin M, Rutter MK. Estimating the causal effect of BMI on mortality risk in people with heart disease, diabetes and cancer using Mendelian randomization. Int J Cardiol. 2021;330:214–20.
Article
PubMed
Google Scholar
Wing RR, Lang W, Wadden TA, Safford M, Knowler WC, Bertoni AG, Hill JO, Brancati FL, Peters A, Wagenknecht L. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care. 2011;34(7):1481–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Arnold SV, Bhatt DL, Barsness GW, Beatty AL, Deedwania PC, Inzucchi SE, Kosiborod M, Leiter LA, Lipska KJ, Newman JD. Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association. Circulation. 2020;141(19):e779–806.
Article
PubMed
Google Scholar
Wexler DJ. Sulfonylureas and cardiovascular safety: the final verdict? JAMA. 2019;322(12):1147–9.
Article
PubMed
Google Scholar
Mannucci E, Monami M, Candido R, Pintaudi B, Targher G, Joint Panel for Italian S-A. Effect of insulin secretagogues on major cardiovascular events and all-cause mortality: a meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis. 2020;30(10):1601–8.
Article
PubMed
CAS
Google Scholar
Powell WR, Christiansen CL, Miller DR. Meta-analysis of sulfonylurea therapy on long-term risk of mortality and cardiovascular events compared to other oral glucose-lowering treatments. Diabetes Ther Res Treat Educ Diabetes Relat Disord. 2018;9(4):1431–40.
CAS
Google Scholar
Xu J, Rajaratnam R. Cardiovascular safety of non-insulin pharmacotherapy for type 2 diabetes. Cardiovasc Diabetol. 2017;16(1):18.
Article
PubMed
PubMed Central
CAS
Google Scholar
AD Association. 9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes—2021. Diabetes Care. 2021;44(Supplement 1):S111–24.
Article
Google Scholar
Anyanwagu U, Mamza J, Donnelly R, Idris I. Association between insulin-induced weight change and CVD mortality: evidence from a historic cohort study of 18,814 patients in UK primary care. Diabetes Metab Res Rev. 2018;34(1):e2945.
Article
CAS
Google Scholar
Doehner W, Erdmann E, Cairns R, Clark AL, Dormandy JA, Ferrannini E, Anker SD. Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population. Int J Cardiol. 2012;162(1):20–6.
Article
PubMed
Google Scholar
Davies MJ. Insulin secretagogues. Curr Med Res Opin. 2002;18(sup1):s22–30.
Article
PubMed
Google Scholar
Janghorbani M, Amini M, Salehi-Marzijarani M. Weight change, blood pressure, lipids and glycemic control among patients with type 2 diabetes. Ann Nutr Metab. 2011;58(2):141–9.
Article
CAS
PubMed
Google Scholar
Esteghamati A, Gouya MM, Abbasi M, Delavari A, Alikhani S, Alaedini F, Safaie A, Forouzanfar M, Gregg EW. Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: national survey of risk factors for non-communicable diseases of Iran. Diabetes Care. 2008;31(1):96–8.
Article
PubMed
Google Scholar
Esteghamati A, Etemad K, Koohpayehzadeh J, Abbasi M, Meysamie A, Noshad S, Asgari F, Mousavizadeh M, Rafei A, Khajeh E. Trends in the prevalence of diabetes and impaired fasting glucose in association with obesity in Iran: 2005–2011. Diabetes Res Clin Pract. 2014;103(2):319–27.
Article
PubMed
Google Scholar
Polemiti E, Baudry J, Kuxhaus O, Jäger S, Bergmann MM, Weikert C, Schulze MB. BMI and BMI change following incident type 2 diabetes and risk of microvascular and macrovascular complications: the EPIC-potsdam study. Diabetologia. 2021;64(4):814–25.
Article
CAS
PubMed
PubMed Central
Google Scholar
Canning KL, Brown RE, Jamnik VK, Kuk JL. Relationship between obesity and obesity-related morbidities weakens with aging. J Gerontol Ser A Biomed Sci Med Sci. 2014;69(1):87–92.
Article
Google Scholar
Rovella V, Anemona L, Cardellini M, Scimeca M, Saggini A, Santeusanio G, Bonanno E, Montanaro M, Legramante IM, Ippoliti A. The role of obesity in carotid plaque instability: interaction with age, gender, and cardiovascular risk factors. Cardiovasc Diabetol. 2018;17(1):46.
Article
CAS
PubMed
PubMed Central
Google Scholar
Brown RE, Kuk JL. Age-related differences in the consequences of obesity on cardiovascular disease, type 2 diabetes, osteoarthritis, cancer, physical function, osteoporosis, cognitive function, and mortality risk in the elderly. Healthy Aging Clin Care Elder. 2014;6:25.
Article
Google Scholar
Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet. 2019;393(10191):2636–46.
Article
PubMed
Google Scholar
Chin SO, Rhee SY, Chon S, Hwang Y-C, Jeong I-K, Oh S, Ahn KJ, Chung HY, Woo J-T, Kim S-W. Sarcopenia is independently associated with cardiovascular disease in older Korean adults: the Korea national health and nutrition examination survey (KNHANES) from 2009. PLoS ONE. 2013;8(3):e60119.
Article
CAS
PubMed
PubMed Central
Google Scholar
Williamson DF, Thompson TJ, Thun M, Flanders D, Pamuk E, Byers T. Intentional weight loss and mortality among overweight individuals with diabetes. Diabetes Care. 2000;23(10):1499–504.
Article
CAS
PubMed
Google Scholar
Gregg EW, Jakicic JM, Blackburn G, Bloomquist P, Bray GA, Clark JM, Coday M, Curtis JM, Egan C, Evans M, et al. Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol. 2016;4(11):913–21.
Article
PubMed
PubMed Central
Google Scholar
De Stefani FDC, Pietraroia PS, Fernandes-Silva MM, Faria-Neto J, Baena CP. Observational evidence for unintentional weight loss in all-cause mortality and major cardiovascular events: a systematic review and meta-analysis. Sci Rep. 2018;8(1):1–11.
CAS
Google Scholar
AD Association. 6. Glycemic targets. Diabetes Care. 2015;38(Supplement 1):S33–40.
Article
Google Scholar